TipRanks
GRI Bio (GRI)
NASDAQ:GRI
US Market
GRI
GRI Bio
RESEARCH TOOLSreports
Want to see GRI full AI Analyst Report?

GRI Bio (GRI) Income Statement

369 Followers

GRI Bio Income Statement

Last quarter (Q2 2026), GRI Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, GRI Bio's net income was $-1.64M. See GRI Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.98M$ 8.23M$ 11.39M$ 2.24M$ 1.06M
Depreciation and Amortization
$ 4.00K$ 4.00K$ 4.00K$ 3.00K$ 73.00K
EBITDA
$ -11.97M$ -8.23M$ -10.95M$ -2.56M$ -989.00K
Operating Income
$ -11.98M$ -8.23M$ -11.39M$ -2.24M$ -1.06M
Other Income/Expenses
$ 21.00K$ 28.00K$ -1.65M$ -978.00K$ -497.00K
Pretax Income
$ -11.96M$ -8.21M$ -13.04M$ -3.22M$ -1.56M
Net Income
$ -11.96M$ -8.21M$ -13.04M$ -3.22M$ -1.56M
Per Share Metrics
Basic EPS
$ -121.80$ 0.33$ -140.45K$ -47.14K$ -2.83K
Diluted EPS
$ -121.80$ 0.33$ -140.45K$ -47.14K$ -2.83K
Weighted Average Shares Outstanding
 98.16K 4.90M 1.58K 1.16K 11.60K
Weighted Average Shares Outstanding (Diluted)
 98.16K 4.92M 1.58K 1.16K 11.60K
Currency in USD

GRI Bio Earnings and Revenue History